Cargando…

Recent advances in cancer immunotherapy

Detalles Bibliográficos
Autor principal: Sun, Weijing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402047/
https://www.ncbi.nlm.nih.gov/pubmed/28434404
http://dx.doi.org/10.1186/s13045-017-0460-9
_version_ 1783231144049770496
author Sun, Weijing
author_facet Sun, Weijing
author_sort Sun, Weijing
collection PubMed
description
format Online
Article
Text
id pubmed-5402047
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54020472017-04-24 Recent advances in cancer immunotherapy Sun, Weijing J Hematol Oncol Editorial BioMed Central 2017-04-24 /pmc/articles/PMC5402047/ /pubmed/28434404 http://dx.doi.org/10.1186/s13045-017-0460-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Editorial
Sun, Weijing
Recent advances in cancer immunotherapy
title Recent advances in cancer immunotherapy
title_full Recent advances in cancer immunotherapy
title_fullStr Recent advances in cancer immunotherapy
title_full_unstemmed Recent advances in cancer immunotherapy
title_short Recent advances in cancer immunotherapy
title_sort recent advances in cancer immunotherapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402047/
https://www.ncbi.nlm.nih.gov/pubmed/28434404
http://dx.doi.org/10.1186/s13045-017-0460-9
work_keys_str_mv AT sunweijing recentadvancesincancerimmunotherapy